Smartphone Sensors to Assess Symptom Relief in Patients With Social Anxiety Disorder Undergoing T… (NCT06732999) | Clinical Trial Compass
CompletedNot Applicable
Smartphone Sensors to Assess Symptom Relief in Patients With Social Anxiety Disorder Undergoing Treatment
Israel40 participantsStarted 2024-11-24
Plain-language summary
The goal of this study is to examine if a digital behavior-based framework, utilizing the BHQ app, can effectively monitor social anxiety symptoms and evaluate the symptom-reducing impact of attentional training for adults (18-65) with social anxiety disorder (SAD), compared to traditional clinical questionnaires and self-reports.
The main questions it aims to answer are:
1. Can the BHQ app provide a reliable digital measure of social anxiety symptoms?
2. Does GC-MRT significantly reduce symptoms of social anxiety as measured through BHQ app monitoring and standard assessment tools?
Researchers will compare the digital BHQ measurements to traditional clinical assessments to see if the app-based measurements is effective in monitoring symptoms relief.
Participants will:
* Complete an initial clinical interview and self-report questionnaires.
* Engage in a computer-based "free-viewing" task for baseline attention assessment using eye tracking.
* Connect to the BHQ app for continuous monitoring throughout the study.
* Undergo attentional training, GC-MRT.
* Complete weekly SPIN assessments.
* Undergo Final evaluation two weeks post-treatment including repeated clinical interviews, self-reports, and the computer-based task to assess changes in attention patterns and symptom reduction.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Normal or corrected vision, without color blindness.
* A primary diagnosis of social anxiety disorder (based on clinician assessment (LSAS), a MINI interview, and an LSAS score above 50).
* Age range of 18-65.
* Ownership of a smartphone that supports the digital monitoring App.
Exclusion Criteria:
* Prior experience with GC-MRT.
* A current diagnosis of post-traumatic stress disorder (PTSD).
* A current or past diagnosis of psychosis or bipolar disorder.
* Neurological disorder (e.g., epilepsy, brain injury).
* Severe suicidal ideation.
* Substance or alcohol addiction.
* Concurrent treatment (pharmacological or psychosocial).
* Pregnancy.
* Insufficient Hebrew proficiency (unable to complete a clinical interview and/or self-report symptoms and/or perform cognitive tasks).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The Liebowitz Social Anxiety Scale (LSAS)
Timeframe: From Pre meeting measurements in week 0 to post training measurements in week 10